Azenta (AZTA) to Release Earnings on Tuesday

Posted by on Aug 3rd, 2026

Azenta (NASDAQ:AZTA – Get Free Report) is expected to be releasing its Q3 2026 results before the market opens on Tuesday, August 4th. Analysts expect the company to post earnings of $0.1138 per share and revenue of $149.2380 million for the quarter. Parties can find conference call details on the company’s upcoming Q3 2026 earning results page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 8:30 AM ET.

Azenta (NASDAQ:AZTA – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of $0.12 by ($0.16). The company had revenue of $144.79 million during the quarter, compared to analyst estimates of $148.47 million. Azenta had a negative net margin of 30.49% and a positive return on equity of 1.23%. The firm’s revenue for the quarter was up 1.4% on a year-over-year basis. During the same quarter last year, the business earned $0.01 EPS.

Azenta Stock Performance

AZTA stock opened at $28.13 on Monday. The company’s 50-day moving average price is $24.68 and its 200 day moving average price is $25.73. Azenta has a 52 week low of $15.93 and a 52 week high of $41.73. The company has a market cap of $1.30 billion, a P/E ratio of -7.10 and a beta of 1.36.

Hedge Funds Weigh In On Azenta

Several hedge funds have recently bought and sold shares of the stock. Integrated Wealth Concepts LLC purchased a new stake in shares of Azenta in the first quarter valued at $435,000. Millennium Management LLC increased its position in Azenta by 214.8% during the 1st quarter. Millennium Management LLC now owns 340,580 shares of the company’s stock worth $11,798,000 after purchasing an additional 232,405 shares in the last quarter. Empowered Funds LLC raised its stake in Azenta by 10.5% in the 1st quarter. Empowered Funds LLC now owns 6,482 shares of the company’s stock valued at $225,000 after purchasing an additional 618 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Azenta by 17.8% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 201,337 shares of the company’s stock valued at $6,974,000 after purchasing an additional 30,492 shares during the last quarter. Finally, Creative Planning purchased a new position in Azenta in the 2nd quarter valued at about $270,000. Hedge funds and other institutional investors own 99.08% of the company’s stock.

Analyst Upgrades and Downgrades

AZTA has been the topic of a number of research analyst reports. Weiss Ratings upgraded Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, July 15th. Needham & Company LLC decreased their price objective on shares of Azenta from $44.00 to $33.00 and set a “buy” rating on the stock in a research report on Wednesday, May 6th. Four research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $40.40.

View Our Latest Report on Azenta

Azenta Company Profile

(Get Free Report)

Azenta, Inc (NASDAQ: AZTA) is a life sciences technology company specializing in sample management, cryogenic storage and genomic services for research and clinical applications. Formerly the Life Sciences division of Brooks Automation, Azenta provides integrated solutions that enable customers to store, track and analyze biological samples with high levels of automation, data integrity and efficiency. Its offerings span automated storage systems, biorepository management software and end‐to‐end sample tracking workflows.

In addition to hardware and informatics platforms for sample storage, Azenta’s Genomics business delivers next‐generation sequencing (NGS), DNA synthesis, and molecular biology services.

Read More

Earnings History for Azenta (NASDAQ:AZTA)

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.